AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $904,861 | -32.1% | 1,988,704 | 0.0% | 0.00% | – |
| Q2 2023 | $1,332,431 | +55.8% | 1,988,704 | 0.0% | 0.00% | – |
| Q1 2023 | $855,142 | +37.9% | 1,988,704 | 0.0% | 0.00% | – |
| Q4 2022 | $620,277 | -46.4% | 1,988,704 | +0.1% | 0.00% | – |
| Q3 2022 | $1,157,000 | -25.4% | 1,987,595 | 0.0% | 0.00% | – |
| Q2 2022 | $1,550,000 | -26.4% | 1,987,595 | 0.0% | 0.00% | – |
| Q1 2022 | $2,107,000 | +14.5% | 1,987,595 | -0.6% | 0.00% | – |
| Q4 2021 | $1,840,000 | -54.5% | 2,000,285 | -0.1% | 0.00% | – |
| Q3 2021 | $4,046,000 | -5.6% | 2,002,856 | +0.5% | 0.00% | – |
| Q2 2021 | $4,285,000 | -2.0% | 1,993,156 | +3.5% | 0.00% | – |
| Q1 2021 | $4,373,000 | +326.6% | 1,926,399 | +236.7% | 0.00% | – |
| Q4 2020 | $1,025,000 | +17.8% | 572,131 | +41.3% | 0.00% | – |
| Q3 2020 | $870,000 | -4.9% | 404,953 | +9.8% | 0.00% | – |
| Q2 2020 | $915,000 | +312.2% | 368,853 | +325.8% | 0.00% | – |
| Q1 2020 | $222,000 | – | 86,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |